In pregnant women, the puzzle of drug safety

In pregnant women, the puzzle of drug safety
In pregnant women, the puzzle of drug safety

Published on May 29, 2024 at 8:42 p.m. / Modified on May 29, 2024 at 8:59 p.m.

When it comes to medications, pregnant women are in a different league. Since the thalidomide scandal which saw more than 10,000 children born with significant malformations in the 1950s and 1960s, they are no longer integrated into clinical research protocols. As a result, data is lacking and for safety reasons, many molecules are not recommended for pregnant women.

Today, paradoxically, it is thanks to those who do not follow the packaging instructions that science advances. Thus, the Vaud University Hospital Center (CHUV) was able to produce data concerning the taking of medications against type 2 diabetes and obesity during the first trimester of pregnancy thanks to 168 women who followed these treatments even though they were not didn’t yet know they were pregnant.

Interested in this item?

To take full advantage of our content, subscribe! Until May 31, take advantage of nearly 15% off the annual offer!

CHECK OFFERS

In-pregnant-women-the-puzzle-of-drug-saf
Good reasons to subscribe to Le Temps:
  • Unlimited access to all content available on the website.
  • Unlimited access to all content available on the mobile application
  • Sharing plan of 5 articles per month
  • Consultation of the digital version of the newspaper from 10 p.m. the day before
  • Access to supplements and T, the Temps magazine, in e-paper format
  • Access to a set of exclusive benefits reserved for subscribers

Already a subscriber?
To log in

-

-

PREV Escalation of bellicose remarks and exchanges of fire
NEXT North Korea: rare images of the holiday camp where children of Russian soldiers were welcomed, according to Putin